Mianserin Hydrochloride: Unraveling Antipathogenic and Me...
2026-04-03
Explore the multifaceted roles of Mianserin Hydrochloride as a 5-HT2 receptor antagonist in both depression and antipathogenic research. This in-depth article reveals new insights into ergosterol depletion, β-cyclodextrin complexation, and metabolic modulation—offering a unique perspective for advanced neuroscience and therapeutic discovery.
Cyclosporin A: Unraveling Its Role in Mitochondrial and I...
2026-04-03
Explore the multifaceted applications of Cyclosporin A as a cyclophilin inhibitor and immunosuppressive agent. This article delves into its unique mitochondrial and cellular mechanisms, offering advanced insights for autoimmune disorder research, cancer, and viral entry studies.
Olaparib (AZD2281): Selective PARP-1/2 Inhibitor for BRCA...
2026-04-02
Olaparib (AZD2281, Ku-0059436) is a highly selective PARP-1/2 inhibitor used in research on BRCA-deficient cancer and DNA damage response. This article details its mechanism, benchmarks in tumor radiosensitization, and practical considerations for cancer model workflows. It clarifies evidence-based applications and common misconceptions for robust, reproducible experimental outcomes.
SR-202: Advanced PPARγ Antagonism for Precision Metabolic...
2026-04-02
Discover how SR-202, a selective PPARγ antagonist, is revolutionizing type 2 diabetes and obesity research by enabling targeted inhibition of PPAR-dependent adipocyte differentiation and metabolic inflammation. Explore unique applications in dissecting nuclear receptor signaling, with in-depth analysis beyond current literature.
Tofacitinib Citrate (CP-690550): Selective JAK3 Inhibitor...
2026-04-01
Explore the unique role of Tofacitinib citrate, a potent JAK3 inhibitor, in dissecting JAK-STAT signaling and modeling autoimmune disease. This article delivers a novel, in-depth focus on endothelial-immune cross-talk and vascular risk, advancing immune regulation research beyond standard protocols.
KPT-330 (Selinexor): Selective CRM1 Inhibitor for Cancer ...
2026-04-01
KPT-330 (Selinexor) is a potent, orally bioavailable, and selective inhibitor of CRM1/XPO1-mediated nuclear export. This compound induces apoptosis and cell cycle arrest in multiple cancer models, including non-small cell lung cancer and triple-negative breast cancer. Its validated mechanism and favorable in vivo profile make it a benchmark tool for translational oncology research.
Fluo-4 AM (SKU B8807): Reliable Calcium Imaging for Cell-...
2026-03-31
This scenario-driven guide examines how Fluo-4 AM (SKU B8807) addresses real-world laboratory challenges in intracellular calcium measurement, offering evidence-based solutions for cell viability, cytotoxicity, and signaling assays. Drawing on recent literature and comparative data, the article highlights the probe's sensitivity, workflow compatibility, and vendor reliability, enabling biomedical researchers to optimize calcium imaging with confidence.
Rewriting the Rules of Therapeutic Resistance: Mechanisti...
2026-03-31
This thought-leadership piece explores the transformative potential of ML385, a selective NRF2 inhibitor, for translational researchers confronting the intertwined challenges of oxidative stress, therapeutic resistance, and ferroptosis. By integrating cutting-edge mechanistic insights—such as the pivotal role of NRF2 in cancer and neurodegeneration—with strategic experimental guidance, this article moves beyond standard product pages to offer a visionary roadmap for leveraging ML385 in both preclinical discovery and the translational pipeline.
Palonosetron Hydrochloride: Precision 5-HT3 Receptor Anta...
2026-03-30
Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist offering sub-nanomolar inhibition and sustained antiemetic efficacy for chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV) prevention. Its dual-site allosteric and orthosteric binding, long half-life, and minimal off-target activity distinguish it as a leading agent in translational and clinical research.
SB 431542: Selective ALK5 Inhibitor for TGF-β Pathway Res...
2026-03-30
SB 431542 is a potent, selective ATP-competitive ALK5 inhibitor used to dissect the TGF-β signaling pathway in cancer, fibrosis, and immunology research. Its benchmark performance in inhibiting Smad2 phosphorylation and cell proliferation makes it a gold standard for experimental modulation of TGF-β responses.
Hydrocortisone: Glucocorticoid Receptor Signaling Modulat...
2026-03-29
Hydrocortisone is a canonical endogenous glucocorticoid hormone and gold-standard modulator of glucocorticoid receptor signaling. As a reference compound, it enables reproducible study of inflammation models, immune regulation, and stress responses in preclinical research. Its molecular specificity, benchmarked purity, and robust solubility protocols make it indispensable for precise in vitro and in vivo experimental design.
Cefepime (BMY-28142): Broad-Spectrum Cephalosporin for Bl...
2026-03-28
Cefepime (BMY-28142) is a broad-spectrum cephalosporin antibiotic with verified efficacy against both Gram-positive and Gram-negative bacteria, including central nervous system infection models. Its blood-brain barrier penetration and established resistance benchmarks make it essential for antibiotic resistance and neurotoxicity studies.
Elevating Transfection Assays: Scenario-Driven Best Pract...
2026-03-27
This article provides scenario-based, evidence-backed guidance for optimizing fluorescence-based transfection assays and mammalian cell gene expression workflows using ARCA EGFP mRNA (SKU R1001). Drawing on real-world laboratory challenges, it demonstrates the practical advantages of this direct-detection reporter mRNA—delivering reliable quantification, superior stability, and reproducibility for rigorous cell viability and protein expression studies.
Sodium Picosulfate: Optimized Workflows for Constipation ...
2026-03-27
APExBIO’s research-grade Sodium Picosulfate unlocks precision in the study of stimulant laxatives, enabling robust workflows for chronic and opioid-induced constipation models. Leverage its superior solubility and purity to streamline in vitro and in vivo assays, troubleshoot common pitfalls, and explore advanced applications from gut–liver–brain axis interrogation to hepatic encephalopathy research.
Oxaliplatin: Platinum-Based Chemotherapeutic Agent Workfl...
2026-03-26
Oxaliplatin stands out in cancer research for its robust DNA adduct formation and apoptosis induction, making it pivotal in metastatic colorectal cancer therapy and resistance studies. This guide details optimized experimental workflows, advanced applications in tumor xenograft models, and troubleshooting strategies—empowering researchers to achieve reproducible, high-impact results.
458 records 23/31 page Previous Next First page 上5页 2122232425 下5页 Last page